C-reactive protein and vulnerability to mental stress-induced myocardial ischemia.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 1829194)

Published in Mol Med on March 23, 2007

Authors

Rahman Shah1, Matthew M Burg, Aseem Vashist, Dorothea Collins, Joyce Liu, Farid Jadbabaie, Brendon Graeber, Christine Earley, Rachel Lampert, Robert Soufer

Author Affiliations

1: Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06520-8017, USA.

Articles cited by this

Inflammation in atherosclerosis. Nature (2002) 28.92

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med (2005) 17.61

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49

Points of control in inflammation. Nature (2002) 10.61

The inflammatory reflex. Nature (2002) 9.10

Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64

Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29

Depression and 18-month prognosis after myocardial infarction. Circulation (1995) 7.22

Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A (2003) 5.26

Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation (1995) 5.06

Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet (1991) 4.02

Widespread coronary inflammation in unstable angina. N Engl J Med (2002) 3.60

Sudden cardiac death triggered by an earthquake. N Engl J Med (1996) 3.27

Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem (2001) 3.17

Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med (2002) 2.83

The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine (1998) 2.70

Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med (1988) 2.61

Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res (2005) 2.46

Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation (2002) 2.32

Mental stress--induced myocardial ischemia and cardiac events. JAMA (1996) 2.20

Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci (Lond) (2001) 2.18

Prognostic implications of mental stress-induced silent left ventricular dysfunction in patients with stable angina pectoris. Am J Cardiol (1995) 1.88

Inflammation in atherosclerosis and implications for therapy. Circulation (2004) 1.71

Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology (1993) 1.67

Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci (2004) 1.60

Impact of socioeconomic status on coronary mortality in people with symptoms, electrocardiographic abnormalities, both or neither: the original Whitehall study 25 year follow up. J Epidemiol Community Health (2000) 1.60

Prognostic value of mental stress testing in coronary artery disease. Am J Cardiol (1999) 1.40

C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study. Circulation (2003) 1.40

Inflammation and coronary artery disease. Am Heart J (2005) 1.39

Effects of mental stress in patients with coronary artery disease: evidence and clinical implications. JAMA (2000) 1.38

Cerebral cortical hyperactivation in response to mental stress in patients with coronary artery disease. Proc Natl Acad Sci U S A (1998) 1.38

Role of behavioral and psychological factors in mental stress-induced silent left ventricular dysfunction in coronary artery disease. J Am Coll Cardiol (1993) 1.33

Indicators of immune activation in major depression. Psychiatry Res (1996) 1.30

Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension (2005) 1.30

Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. BMJ (1997) 1.26

Antidepressant therapy and C-reactive protein levels. Br J Psychiatry (2006) 1.24

Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation (2005) 1.24

Depressed mood is related to high-frequency heart rate variability during stressors. Psychosom Med (2001) 1.19

Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol (1998) 1.17

Effects of an angry temperament on coronary heart disease risk : The Atherosclerosis Risk in Communities Study. Am J Epidemiol (2001) 1.13

Acute phase proteins in major depression. J Psychosom Res (1997) 1.09

Triggers of acute coronary syndromes. Prog Cardiovasc Dis (2002) 1.08

Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol (1996) 1.04

Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation (1995) 1.03

Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation (1996) 1.02

The inflammatory reflex--introduction. J Intern Med (2005) 1.02

Socioeconomic status and health: is parasympathetic nervous system activity an intervening mechanism? Int J Epidemiol (2005) 0.93

Transient left ventricular dysfunction during provocative mental stress in patients with coronary artery disease. Am Heart J (1989) 0.91

Effects of daily stress on autonomic cardiac control in patients with coronary artery disease. Am J Cardiol (2004) 0.89

Personality and social predictors of atherosclerotic progression: Edinburgh Artery Study. Psychosom Med (2001) 0.88

The effects of effort-reward imbalance on inflammatory and cardiovascular responses to mental stress. Psychosom Med (2006) 0.87

Mental stress ischemia: present status and future goals. J Nucl Cardiol (2005) 0.87

Quantification of technetium 99m-labeled sestamibi single-photon emission computed tomography based on mean counts improves accuracy for assessment of relative regional myocardial blood flow: experimental validation in a canine model. J Nucl Cardiol (1996) 0.81

Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease. Am J Cardiol (1996) 0.81

Neurocardiac interaction during stress-induced myocardial ischemia: how does the brain cope? Circulation (2004) 0.80

Triggering and the pathophysiology of acute coronary syndromes. Am Heart J (1997) 0.76

Articles by these authors

The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation (2006) 4.25

Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41

Yield of diagnostic tests in evaluating syncopal episodes in older patients. Arch Intern Med (2009) 3.34

Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med (2004) 2.84

Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol (2005) 2.61

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med (2002) 2.59

Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57

MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry (2003) 2.51

The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol (2003) 2.34

Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol (2006) 2.23

Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry (2010) 2.15

Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med (2010) 2.12

Emotional and physical precipitants of ventricular arrhythmia. Circulation (2002) 2.09

Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA (2006) 2.07

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol (2002) 2.07

Implantable cardioverter-defibrillator shocks increase T-wave alternans. J Cardiovasc Electrophysiol (2007) 2.05

Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol (2009) 2.00

Patient preferences for deactivation of implantable cardioverter-defibrillators. JAMA Intern Med (2013) 1.74

Electrophysiologic characteristics of anger-triggered arrhythmias. Heart Rhythm (2006) 1.67

Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks. Pacing Clin Electrophysiol (2004) 1.65

Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64

Noninvasive detection of risk for emotion-provoked myocardial ischemia. Psychosom Med (2008) 1.63

Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse. Biol Psychiatry (2003) 1.61

Safety of pacemaker implantation in nonagenarians: an analysis of the healthcare cost and utilization project-nationwide inpatient sample. Circulation (2013) 1.56

Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J (2010) 1.53

Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50

Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics. JACC Cardiovasc Imaging (2009) 1.48

Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol (2005) 1.46

Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease. Am J Kidney Dis (2004) 1.44

Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil (2003) 1.41

Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®. Pacing Clin Electrophysiol (2012) 1.40

Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™. J Cardiovasc Electrophysiol (2012) 1.39

The psychosocial context impacts medication adherence after acute coronary syndrome. Ann Behav Med (2014) 1.39

Balancing Model Performance and Simplicity to Predict Postoperative Primary Care Blood Pressure Elevation. Anesth Analg (2015) 1.39

Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival. Neoplasia (2010) 1.36

Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care (2003) 1.35

Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res (2012) 1.35

Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer. PLoS One (2012) 1.31

Presurgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery. Psychosom Med (2003) 1.29

High throughput interrogation of somatic mutations in high grade serous cancer of the ovary. PLoS One (2011) 1.28

Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J (2006) 1.28

The relationship between preoperative and primary care blood pressure among veterans presenting from home for surgery: is there evidence for anesthesiologist-initiated blood pressure referral? Anesth Analg (2011) 1.27

Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med (2003) 1.26

Posttraumatic stress due to an acute coronary syndrome increases risk of 42-month major adverse cardiac events and all-cause mortality. J Psychiatr Res (2011) 1.25

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace (2010) 1.25

Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res (2008) 1.23

Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm (2006) 1.20

Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med (2004) 1.16

Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J (2013) 1.13

Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm (2009) 1.12

Depressive symptoms and heart rate variability: evidence for a shared genetic substrate in a study of twins. Psychosom Med (2008) 1.12

Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Circ Cardiovasc Qual Outcomes (2011) 1.12

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations. PLoS One (2013) 1.11

Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial. Psychother Psychosom (2007) 1.10

Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc (2004) 1.10

Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES]). Am J Cardiol (2010) 1.09

Posttraumatic stress disorder and impaired autonomic modulation in male twins. Biol Psychiatry (2013) 1.08

Is heart rate variability related to memory performance in middle-aged men? Psychosom Med (2011) 1.07

Widowhood and mortality: a meta-analysis and meta-regression. Demography (2012) 1.06

Effects of psychologic stress on repolarization and relationship to autonomic and hemodynamic factors. J Cardiovasc Electrophysiol (2005) 1.06

The true incremental cost of ECG screening: the price is not right, but the cost appears effective. J Am Coll Cardiol (2013) 1.05

The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial. J Cardiopulm Rehabil (2006) 1.05

Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®. Pacing Clin Electrophysiol (2013) 1.05

Depression and five year survival following acute myocardial infarction: a prospective study. J Affect Disord (2008) 1.04

Effect of social support on nocturnal blood pressure dipping. Psychosom Med (2007) 1.03

Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease. J Lipid Res (2010) 1.03

Long term clinical trials: how much information do participants retain from the informed consent process? Contemp Clin Trials (2006) 1.01

Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol (2008) 1.01

Therapy for mental stress-induced myocardial ischemia. JAMA (2013) 1.00

Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiency. Kidney Int (2004) 0.96

Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Metabolism (2008) 0.95

Depression vulnerabilities in patients with different levels of depressive symptoms after acute coronary syndromes. Psychother Psychosom (2006) 0.95

Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med (2006) 0.92

Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience. Am Heart J (2008) 0.92

Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. Int J Behav Med (2009) 0.91

Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression. J Clin Psychiatry (2010) 0.91

Aspirin adherence, depression and one-year prognosis after acute coronary syndrome. Psychother Psychosom (2011) 0.91

Triggering of symptomatic atrial fibrillation by negative emotion. J Am Coll Cardiol (2014) 0.90

Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial. J Lipid Res (2004) 0.89

Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery disease. Psychosom Med (2010) 0.89

Does ICD indication affect quality of life and levels of distress? Pacing Clin Electrophysiol (2009) 0.89

Current perspective on mental stress-induced myocardial ischemia. Psychosom Med (2014) 0.88

Depression predicts elevated endothelin-1 in patients with coronary artery disease. Psychosom Med (2010) 0.88